Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
NCT07278388
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- PASC Post Acute Sequelae of COVID 19
- Fatigue
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Last updated on ClinicalTrials.gov
- December 12, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- Kennedy Krieger Institute · Baltimore, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.